from other thread:
You knew this was eventually coming. And if this particular design doesn't fly or make it through clinical trials, another pharma/biotech company will come up with one that will.
The e-cig market has been wide open for something like this in the USA for 2 - 3 years now. Any current e-cig manufacturer with enough confidence, clinically, in their product could have done this. Even if they didn't "have" the money up-front, enough confidence and proper business strategy could have gotten them the needed venture capital.
The really bad thing about this for the current e-cig industry IMO is that, regardless if the eventually approved product matches up to e-cigs in vaper's eyes; it will give the FDA an APPROVED e-cig like entity with which to go to battle. They can then easily enforce an immediate ban on any UNAPPROVED e-cig design. If I was an e-cig manufacturer/supplier I would be looking , immediately, to counter this by getting my product up to speed and beating the Pharma competition to the punch via my own clinical trial. Otherwise, the game , as they say, may be up.